Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v5-EN
Language English English
Date Updated 2019-12-24 2019-12-24
Drug Identification Number 02091135 02091135
Brand name MICRO PLUS 4 REGULAR STRENGTH MICRO PLUS 4 REGULAR STRENGTH
Common or Proper name MICRO + 4 REGULAR MICRO + 4 REGULAR
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients MANGANESE CHROMIUM ZINC COPPER MANGANESE CHROMIUM ZINC COPPER
Strength(s) .1MG 4MCG 1MG .4MG .1MG 4MCG 1MG .4MG
Dosage form(s) LIQUID LIQUID
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 vials 10 vials
ATC code B05XA B05XA
ATC description I.V. SOLUTION ADDITIVES I.V. SOLUTION ADDITIVES
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2019-12-02 2019-12-02
Estimated end date 2019-12-18 2019-12-18
Actual end date 2019-12-23 2019-12-23
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Limited supply at Baxter - On allocation at 100% of historical usage Limited supply at Baxter - On allocation at 100% of historical usage
Health Canada comments